IMNN Imunon Inc.

Subscribe to $IMNN

Imunon Inc.

Subscribe to $IMNN

$IMNN

Biotechnology: Pharmaceutical Preparations

Health Care

IPO Year:

Exchange: NASDAQ

Recent Analyst Ratings for Imunon Inc.

Date	Price Target	Rating	Analyst

See more ratings

Imunon Inc. SEC Filings

SEC Form EFFECT filed by Imunon Inc.
EFFECT - Imunon, Inc. (0000749647) (Filer)
6/16/25 12:15:23 AM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
Imunon Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Imunon, Inc. (0000749647) (Filer)
6/13/25 5:15:37 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 424B3 filed by Imunon Inc.
424B3 - Imunon, Inc. (0000749647) (Filer)
6/13/25 5:10:28 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form DEF 14A filed by Imunon Inc.
DEF 14A - Imunon, Inc. (0000749647) (Filer)
6/9/25 4:30:21 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
Imunon Inc. filed SEC Form 8-K: Other Events
8-K - Imunon, Inc. (0000749647) (Filer)
6/9/25 2:35:19 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form S-1 filed by Imunon Inc.
S-1 - Imunon, Inc. (0000749647) (Filer)
5/30/25 5:03:35 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form PRE 14A filed by Imunon Inc.
PRE 14A - Imunon, Inc. (0000749647) (Filer)
5/30/25 4:45:35 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
Imunon Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Imunon, Inc. (0000749647) (Filer)
5/30/25 4:30:51 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form D filed by Imunon Inc.
D - Imunon, Inc. (0000749647) (Filer)
5/28/25 4:15:35 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
Imunon Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
8-K - Imunon, Inc. (0000749647) (Filer)
5/27/25 7:30:56 AM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care

Imunon Inc. Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Braun Donald P bought $29,480 worth of shares (25,000 units at $1.18), increasing direct ownership by 4,188% to 25,597 units (SEC Form 4)
4 - Imunon, Inc. (0000749647) (Issuer)
1/28/25 4:18:24 PM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
President and CEO Lindborg Stacy bought $24,500 worth of Imunon Common Stock (25,000 units at $0.98), increasing direct ownership by 10% to 264,166 units (SEC Form 4)
4 - Imunon, Inc. (0000749647) (Issuer)
8/16/24 8:03:50 AM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care
Executive Chairman of Board Tardugno Michael H bought $25,750 worth of Imunon Common Stock (25,000 units at $1.03), increasing direct ownership by 8% to 353,346 units (SEC Form 4)
4 - Imunon, Inc. (0000749647) (Issuer)
8/16/24 8:01:30 AM ET
$IMNN
Biotechnology: Pharmaceutical Preparations
Health Care

Imunon Inc.

Recent Analyst Ratings for Imunon Inc.

Imunon Inc. SEC Filings

SEC Form EFFECT filed by Imunon Inc.

Imunon Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

SEC Form 424B3 filed by Imunon Inc.

SEC Form DEF 14A filed by Imunon Inc.

Imunon Inc. filed SEC Form 8-K: Other Events

SEC Form S-1 filed by Imunon Inc.

SEC Form PRE 14A filed by Imunon Inc.

Imunon Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

SEC Form D filed by Imunon Inc.

Imunon Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

Imunon Inc. Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Braun Donald P bought $29,480 worth of shares (25,000 units at $1.18), increasing direct ownership by 4,188% to 25,597 units (SEC Form 4)

President and CEO Lindborg Stacy bought $24,500 worth of Imunon Common Stock (25,000 units at $0.98), increasing direct ownership by 10% to 264,166 units (SEC Form 4)

Executive Chairman of Board Tardugno Michael H bought $25,750 worth of Imunon Common Stock (25,000 units at $1.03), increasing direct ownership by 8% to 353,346 units (SEC Form 4)